• SCIENCE
  • Research Areas
  • Pipeline
  • Partnership
  • NEWS & PRESS
  • pressReleases
  • newsMedia
  • CAREERS
  • Career Openings
  • CONTACT US
  • WE DISCOVER AND DEVELOP NOVEL AND

    DIFFERENTIATED THERAPIES IN CANCER AND BEYOND

    ADDRESS UNMET MEDICAL NEEDS FOR PATIENTS IN CHINA AND GLOBALLY

    Founded in 2016, we have established a robust in-house R&D engine underpinned by an oustanding discovery team and multi-dimensional discovery platform. We have strategically designed and developed a rich pipeline of 10+ small molecule programs focused on oncology.

    01---
    02---

    Founders

    -------------------------------------------------

    Our company was founded by a group of experiened drug hunters with strong passion, proven track records in drug discovery, and rich experience in managing multiple large R&D organizations.

    Dr. Yao-Chang Xu
    Founder & CEO
    Dr. Yao-Chang Xu
    Founder & CEO
    Dr. Yao-Chang Xu has more than 25 years of drug dis...
    Dr. Hongping Yu
    Co-founder, SVP of Chemistry
    Dr. Hongping Yu
    Co-founder, SVP of Chemistry
    Dr. Hongping Yu has worked in drug discovery and de...
    Dr. Zhui Chen
    Co-founder, SVP of Biology
    Dr. Zhui Chen
    Co-founder, SVP of Biology
    Dr. Zhui Chen is a seasoned biologist and drug hunt...

    Our Scientific Focus

    small molecule precision oncology & immuno-oncology therapies

    Our Pipeline

    Consists of a broad range of small-molecule
    precision-oncology and immuno-oncology product candidates

    Partnership

    We have established and continue to explore broad partnership 

    and collaboration with industry and academic leaders

    News & Press

    VISION & MISSION

    We aspire to become a leading biopharmaceutical company to discover and develop novel and differentiated therapies in cancer and beyond, addressing critical unmet needs for patients in China and globally.

    Investors

    Since our establishment, we have completed four rounds of financing led by blue-chip investors. Our investor base is a testament to our capabilities and provides strong financial supports and industry insights to our future success.

    Tel:(+86) 021-68912098

    E-Mail:Public@abbisko.com Bd@abbisko.com

    Copyright © 2021 All rights reserved:Abbisko Therapeautics     沪ICP备17056565号-1   

    {{currentdata.name}}
    {{currentdata.post}}